CALA logo

Calithera Biosciences (CALA) Cash From Operations

Annual CFO

-$43.61 M
+$22.69 M+34.23%

December 31, 2022

Summary

Performance

1-Year Change

+34.23%

3-Year Change

+44.62%

5-Year Change

-417.13%

15-Year Change

-417.13%

CALA Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

30.11%
CALA annual cash flow from operations is higher than 30.11% of companies in Healthcare sector

High & Low

All-time High

$13.75 M
CALA annual cash flow from operations is currently -417.13% below its historical high of $13.75 million

3-Year Low

-$66.30 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2022
CALA previous annual earnings announcement was published on Dec 31, 2022

Next Annual Earnings Report Date

N/A
CALA next annual earnings announcement has not yet been scheduled

OtherCALAcash flowmetrics:

Annual CFI

-$133.00 K
CALA annual cash flow from investing activities is -$133.00 thousand

Annual CFF

$9.65 M
CALA annual cash flow from financing activities is $9.65 million

Annual FCF

-$43.74 M
CALA annual free cash flow is -$43.74 million

Annual CAPEX

-
CALA annual capital expenditures value is unknown

Quarterly CFO

-$8.60 M
-$862.00 K-11.14%

December 31, 2022

Summary

Performance

3-Month Change

-11.14%

1-Year Change

+46.3%

3-Year Change

+53.26%

5-Year Change

+24.33%

CALA Quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

34.42%
CALA quarterly cash flow from operations is higher than 34.42% of companies in Healthcare sector

High & Low

All-time High

$35.25 M
CALA quarterly cash flow from operations is currently -124.39% below its historical high of $35.25 million

3-Year Low

-$25.57 M

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2022
CALA previous earnings announcement was published on Dec 31, 2022

Next Quarterly Earnings Report Date

N/A
CALA next earnings announcement has not yet been scheduled

OtherCALAcash flowmetrics:

Quarterly CFI

-$23.00 K
CALA quarterly cash flow from investing activities is -$23.00 thousand

Quarterly CFF

$4000.00
CALA quarterly cash flow from financing activities is $4000.00

Quarterly FCF

-$8.62 M
CALA quarterly free cash flow is -$8.62 million

Quarterly CAPEX

-
CALA quarterly capital expenditures value is unknown

TTM CFO

-$43.61 M
+$16.97 M+28.02%

December 31, 2022

Summary

Performance

3-Month Change

+28.02%

1-Year Change

+27.69%

3-Year Change

+44.62%

5-Year Change

+44.62%

CALA TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

31.07%
CALA TTM cash flow from operations is higher than 31.07% of companies in Healthcare sector

High & Low

All-time High

$20.64 M
CALA TTM cash flow from operations is currently -311.26% below its historical high of $20.64 million

3-Year Low

-$66.30 M

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2022
CALA previous earnings announcement was published on Dec 31, 2022

Next Quarterly Earnings Report Date

N/A
CALA next earnings announcement has not yet been scheduled

OtherCALAcash flowmetrics:

TTM CFI

-$133.00 K
CALA TTM cash flow from investing activities is -$133.00 thousand

TTM CFF

$9.65 M
CALA TTM cash flow from financing activities is $9.65 million

TTM FCF

-$43.74 M
CALA TTM free cash flow is -$43.74 million

TTM CAPEX

-
CALA TTM capital expenditures value is unknown

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

CALA Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+34.2%+46.3%+27.7%
3 y3 years+44.6%+53.3%+44.6%
5 y5 years-417.1%+24.3%+44.6%

CALA Cash From Operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+34.2%-11.1%+66.4%at high+34.2%
5 y5-yearat high+48.3%-13.1%+68.2%at high+48.8%
alltimeall time-417.1%+48.3%-124.4%+68.2%-311.3%+48.8%

Calithera Biosciences Cash From Operations History

DateAnnualQuarterlyTTM
Dec 2022
-$43.61 M(-34.2%)
-$8.60 M(+11.1%)
-$43.61 M(-28.0%)
Sep 2022
-
-$7.74 M(-31.3%)
-$60.58 M(+0.2%)
Jun 2022
-
-$11.26 M(-29.6%)
-$60.45 M(+0.2%)
Mar 2022
-
-$16.01 M(-37.4%)
-$60.31 M(-9.0%)
Dec 2021
-$66.30 M(-21.4%)
-$25.57 M(+236.3%)
-$66.30 M(+4.0%)
Sep 2021
-
-$7.61 M(-31.6%)
-$63.73 M(-12.0%)
Jun 2021
-
-$11.12 M(-49.5%)
-$72.42 M(-8.7%)
Mar 2021
-
-$22.00 M(-4.3%)
-$79.30 M(-5.9%)
Dec 2020
-$84.31 M(+7.1%)
-$23.00 M(+41.1%)
-$84.31 M(+5.8%)
Sep 2020
-
-$16.30 M(-9.4%)
-$79.71 M(-4.1%)
Jun 2020
-
-$18.00 M(-33.4%)
-$83.08 M(-2.4%)
Mar 2020
-
-$27.02 M(+46.9%)
-$85.14 M(+8.1%)
Dec 2019
-$78.75 M(+21.4%)
-$18.39 M(-6.5%)
-$78.75 M(+6.1%)
Sep 2019
-
-$19.68 M(-1.9%)
-$74.24 M(+4.4%)
Jun 2019
-
-$20.05 M(-2.8%)
-$71.12 M(+0.9%)
Mar 2019
-
-$20.62 M(+48.5%)
-$70.51 M(+8.7%)
Dec 2018
-$64.84 M
-$13.89 M(-16.1%)
-$64.84 M(+4.1%)
Sep 2018
-
-$16.56 M(-14.8%)
-$62.32 M(+9.2%)
Jun 2018
-
-$19.44 M(+30.0%)
-$57.06 M(+56.5%)
DateAnnualQuarterlyTTM
Mar 2018
-
-$14.95 M(+31.6%)
-$36.45 M(-365.1%)
Dec 2017
$13.75 M(-144.3%)
-$11.36 M(+0.5%)
$13.75 M(-15.8%)
Sep 2017
-
-$11.30 M(-1067.9%)
$16.34 M(-20.8%)
Jun 2017
-
$1.17 M(-96.7%)
$20.64 M(+74.5%)
Mar 2017
-
$35.25 M(-501.8%)
$11.83 M(-138.1%)
Dec 2016
-$31.02 M(+3.6%)
-$8.77 M(+25.3%)
-$31.02 M(-3.5%)
Sep 2016
-
-$7.00 M(-8.3%)
-$32.17 M(+1.9%)
Jun 2016
-
-$7.64 M(+0.5%)
-$31.55 M(+5.5%)
Mar 2016
-
-$7.61 M(-23.3%)
-$29.91 M(-0.1%)
Dec 2015
-$29.93 M(+55.6%)
-$9.91 M(+55.1%)
-$29.93 M(+22.2%)
Sep 2015
-
-$6.39 M(+6.6%)
-$24.49 M(+3.1%)
Jun 2015
-
-$6.00 M(-21.4%)
-$23.75 M(+6.3%)
Mar 2015
-
-$7.63 M(+70.6%)
-$22.34 M(+16.2%)
Dec 2014
-$19.23 M(+62.5%)
-$4.47 M(-21.0%)
-$19.23 M(+30.3%)
Sep 2014
-
-$5.66 M(+23.5%)
-$14.76 M(+62.1%)
Jun 2014
-
-$4.58 M(+1.3%)
-$9.10 M(+101.3%)
Mar 2014
-
-$4.52 M
-$4.52 M
Dec 2013
-$11.84 M(+69.3%)
-
-
Dec 2012
-$6.99 M
-
-

FAQ

  • What is Calithera Biosciences annual cash flow from operations?
  • What is the all time high annual CFO for Calithera Biosciences?
  • What is Calithera Biosciences annual CFO year-on-year change?
  • What is Calithera Biosciences quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Calithera Biosciences?
  • What is Calithera Biosciences quarterly CFO year-on-year change?
  • What is Calithera Biosciences TTM cash flow from operations?
  • What is the all time high TTM CFO for Calithera Biosciences?
  • What is Calithera Biosciences TTM CFO year-on-year change?

What is Calithera Biosciences annual cash flow from operations?

The current annual CFO of CALA is -$43.61 M

What is the all time high annual CFO for Calithera Biosciences?

Calithera Biosciences all-time high annual cash flow from operations is $13.75 M

What is Calithera Biosciences annual CFO year-on-year change?

Over the past year, CALA annual cash flow from operations has changed by +$22.69 M (+34.23%)

What is Calithera Biosciences quarterly cash flow from operations?

The current quarterly CFO of CALA is -$8.60 M

What is the all time high quarterly CFO for Calithera Biosciences?

Calithera Biosciences all-time high quarterly cash flow from operations is $35.25 M

What is Calithera Biosciences quarterly CFO year-on-year change?

Over the past year, CALA quarterly cash flow from operations has changed by +$7.41 M (+46.30%)

What is Calithera Biosciences TTM cash flow from operations?

The current TTM CFO of CALA is -$43.61 M

What is the all time high TTM CFO for Calithera Biosciences?

Calithera Biosciences all-time high TTM cash flow from operations is $20.64 M

What is Calithera Biosciences TTM CFO year-on-year change?

Over the past year, CALA TTM cash flow from operations has changed by +$16.70 M (+27.69%)